138 related articles for article (PubMed ID: 31203533)
1. The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System.
García-Domínguez M; Aguirre A; Lastra A; Hidalgo A; Baamonde A; Menéndez L
Cell Mol Neurobiol; 2019 Nov; 39(8):1115-1124. PubMed ID: 31203533
[TBL] [Abstract][Full Text] [Related]
2. Kappa-opioid receptor-mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice.
García-Domínguez M; González-Rodríguez S; Hidalgo A; Baamonde A; Menéndez L
Fundam Clin Pharmacol; 2021 Dec; 35(6):1109-1118. PubMed ID: 33905573
[TBL] [Abstract][Full Text] [Related]
3. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.
Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL
J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851
[TBL] [Abstract][Full Text] [Related]
4. Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System.
Oliveira CD; Veloso CC; Ferreira RC; Lage GA; Pimenta LP; Duarte ID; Romero TR; Perez AC
Planta Med; 2017 Feb; 83(3-04):261-267. PubMed ID: 27574895
[TBL] [Abstract][Full Text] [Related]
5. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
6. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
7. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
Hutch CR; Hillard CJ; Jia C; Hegg CC
Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
[TBL] [Abstract][Full Text] [Related]
8. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
Zychowska M; Rojewska E; Piotrowska A; Kreiner G; Nalepa I; Mika J
Int Immunopharmacol; 2017 Nov; 52():261-271. PubMed ID: 28961489
[TBL] [Abstract][Full Text] [Related]
9. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M
J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856
[TBL] [Abstract][Full Text] [Related]
10. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
13. N-(4-Methoxy-2-nitrophenyl)hexadecanamide, a palmitoylethanolamide analogue, reduces formalin-induced nociception.
Roa-Coria JE; Navarrete-Vázquez G; Fowler CJ; Flores-Murrieta FJ; Déciga-Campos M; Granados-Soto V
Life Sci; 2012 Dec; 91(25-26):1288-94. PubMed ID: 23069585
[TBL] [Abstract][Full Text] [Related]
14. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
15. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
16. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex.
Sticht MA; Limebeer CL; Rafla BR; Abdullah RA; Poklis JL; Ho W; Niphakis MJ; Cravatt BF; Sharkey KA; Lichtman AH; Parker LA
Neuropharmacology; 2016 Mar; 102():92-102. PubMed ID: 26541329
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CCR8 is required for lipopolysaccharide-triggered cytokine production in mouse peritoneal macrophages.
Oshio T; Kawashima R; Kawamura YI; Hagiwara T; Mizutani N; Okada T; Otsubo T; Inagaki-Ohara K; Matsukawa A; Haga T; Kakuta S; Iwakura Y; Hosokawa S; Dohi T
PLoS One; 2014; 9(4):e94445. PubMed ID: 24714157
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?
Milligan AL; Szabo-Pardi TA; Burton MD
J Dual Diagn; 2020; 16(1):106-119. PubMed ID: 31596190
[TBL] [Abstract][Full Text] [Related]
20. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]